Pharmafile Logo

Glaucoma in perspective

Pfizer strikes genetic research deal with 23andMe

Lupus study and research community forms just one part of their collaboration

- PMLiVE

Havas Group acquires German comms agency Bird & Schulte

Freiburg-based firm will now operate as Havas Life Bird & Schulte

- PMLiVE

Pharma can learn to invent like an entrepreneur

Why pharma firms don’t always have to behave like corporations

- PMLiVE

UCB submits brivaracetam for use in epilepsy

Files drug in both the US and EU

- PMLiVE

Genzyme’s oral Gaucher drug cleared in Europe

Cerdelga now available to adults with type 1 Gaucher disease

- PMLiVE

AZ files gout drug lesinurad in Europe

Acquired drug as part of its takeover of Ardea Biosciences in 2012

- PMLiVE

MedImmune partners with US National Cancer Institute

Will research immunotherapies, imaging and stem cell treatments

- PMLiVE

Bupa launches UK ad campaign

TV campaign highlights support services for patients

- PMLiVE

Pfizer names head of Germany business

Peter Albiez has been with pharma company since 1996

- PMLiVE

J&J chief predicts 10 new pharma filings by 2017

 Company has launched 14 new products since 2009

- PMLiVE

FDA approves AbbVie’s Duopa in advanced Parkinson’s

Drug is administered into the stomach via a tube

- PMLiVE

BMS names Giovanni Caforia as new CEO

Current chief operating officer will succeed Lamberto Andreotti in May

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links